Brief: Fusion Pharma To Collaborate With Pepscan To Develop Peptide-Based Radiopharmaceuticals
11/01/2022 14:39
Jan 11 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION
WITH
PEPSCAN TO DEVELOP PEPTIDE-BASED RADIOPHARMACEUTICALS
* FUSION PHARMACEUTICALS - UNDER AGREEMENT, CO HAS GLOBAL
RIGHTS
TO DEVELOP AND COMMERCIALIZE ANY PEPTIDES DISCOVERED UNDER
COLLABORATION
Source text for Eikon: ID:nPn5zFKlda
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary